CXCL5 蛋白
-
- 抗原 See all CXCL5 蛋白
- CXCL5 (Chemokine (C-X-C Motif) Ligand 5 (CXCL5))
- 蛋白类型
- Recombinant
- 生物活性
- Active
-
宿主
- 小鼠
-
资源
- 大肠杆菌(E. Coli)
- 序列
- APSSVIAATE LRCVCLTVTP KINPKLIANL EVIPAGPQCP TVEVIAKLKN QKEVCLDPEA PVIKKIIIQK ILGSDKKKAK RNALAVERTA SVQ
- 产品特性
-
Purified recombinant Mouse LIX protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoattract human neutrophils using a concentration range of 10-100 ng/mL. - 纯度
- > 98 % pure
- 内毒素水平
- < 0.1 ng per µg (1 EU/µg).
- Top Product
- Discover our top product CXCL5 蛋白
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 缓冲液
- Supplied as a lyophilized powder.
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- RT/-20 °C
-
- 抗原
- CXCL5 (Chemokine (C-X-C Motif) Ligand 5 (CXCL5))
- 别名
- LIX (CXCL5 产品)
- 别名
- ENA-78 Protein, SCYB5 Protein, Cxcl6 Protein, CXCL5 Protein, GCP-2 Protein, GCP2 Protein, SCYB6 Protein, AMCF-II Protein, LIX Protein, Scyb5 Protein, Scyb6 Protein, C-X-C motif chemokine ligand 5 Protein, C-X-C motif chemokine ligand 6 Protein, chemokine (C-X-C motif) ligand 5 Protein, C-X-C motif chemokine 5 Protein, CXCL5 Protein, Cxcl6 Protein, LOC701946 Protein, LOC703222 Protein, Cxcl5 Protein
- 背景
-
The Mouse homolog of ENA-78 is called LIX. ENA-78/LIX is a CXC chemokine that signals through the CXCR2 receptor. It is expressed in monocytes, platelets, endothelial cells, and mast cells. ENA-78/LIX is a chemoattractant for neutrophils. The three naturally occurring variants of human ENA-78, ENA 5-78, ENA 9-78 and ENA 10-78, contain 74, 70, and 69 amino acid residues, respectively, and possess the same biological activity. ENA-78/LIX contains the four conserved cysteine residues present in CXC chemokines, and also contains the 'ELR' motif common to CXC chemokine that bind to the CXCR1 and CXCR2 receptors.
Alternative Names: CXCL5 protein, ENA-78 protein - 分子量
- 9.8 kDa
- 途径
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity
-